[go: up one dir, main page]

NO962321D0 - Nye krystallformer av vannfritt 7-([1,5,6Å-6-amino-3-azabicyklo [3.1.0Å heks-3-yl)-6-fluoro-1-2,4-difluorfenyl)-1,4-dihydro-4-okso-1,8-naftyridin-3-karboksylsyre-metansulfonsyresalt - Google Patents

Nye krystallformer av vannfritt 7-([1,5,6Å-6-amino-3-azabicyklo [3.1.0Å heks-3-yl)-6-fluoro-1-2,4-difluorfenyl)-1,4-dihydro-4-okso-1,8-naftyridin-3-karboksylsyre-metansulfonsyresalt

Info

Publication number
NO962321D0
NO962321D0 NO962321A NO962321A NO962321D0 NO 962321 D0 NO962321 D0 NO 962321D0 NO 962321 A NO962321 A NO 962321A NO 962321 A NO962321 A NO 962321A NO 962321 D0 NO962321 D0 NO 962321D0
Authority
NO
Norway
Prior art keywords
naphthyridine
azabicyclo
difluorophenyl
hex
dihydro
Prior art date
Application number
NO962321A
Other languages
English (en)
Other versions
NO305599B1 (no
NO962321L (no
Inventor
Lynne A Handanyan
Robert L Hendrickson
Phillip J Johnson
Thomas A Morris
Thimothy Norris
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO962321D0 publication Critical patent/NO962321D0/no
Publication of NO962321L publication Critical patent/NO962321L/no
Publication of NO305599B1 publication Critical patent/NO305599B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO962321A 1995-06-06 1996-06-05 Nye krystallformer av vannfritt 7-([1<alfa>,5<alfa>,6<alfa>]-6-amino-3-azabicyklo [3.1.0] heks-3-yl)-6-fluor-1-(2,4-difluorfenyl)-1,4-dihydro-4-okso-1,8-naftyridin-3-karboksylsyre-metansulfonsyresalt, fremgangsmÕte ved fremstilling derav og farm NO305599B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1995/007211 WO1996039406A1 (en) 1995-06-06 1995-06-06 NOVEL CRYSTAL FORM OF ANHYDROUS 7-([1α, 5α, 6α]-6-AMINO-3-AZABICYCLO[3.1.0]HEX-3-YL)-6-FLUORO-1-(2,4-DIFLUOROPHENYL)-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID, METHANESULFONIC ACID SALT

Publications (3)

Publication Number Publication Date
NO962321D0 true NO962321D0 (no) 1996-06-05
NO962321L NO962321L (no) 1996-12-09
NO305599B1 NO305599B1 (no) 1999-06-28

Family

ID=39431076

Family Applications (1)

Application Number Title Priority Date Filing Date
NO962321A NO305599B1 (no) 1995-06-06 1996-06-05 Nye krystallformer av vannfritt 7-([1<alfa>,5<alfa>,6<alfa>]-6-amino-3-azabicyklo [3.1.0] heks-3-yl)-6-fluor-1-(2,4-difluorfenyl)-1,4-dihydro-4-okso-1,8-naftyridin-3-karboksylsyre-metansulfonsyresalt, fremgangsmÕte ved fremstilling derav og farm

Country Status (38)

Country Link
US (1) US5763454A (no)
EP (1) EP0789697B1 (no)
JP (1) JP3145715B2 (no)
KR (1) KR100191989B1 (no)
CN (1) CN1055474C (no)
AR (1) AR002753A1 (no)
AU (1) AU703634B2 (no)
BG (1) BG62443B1 (no)
BR (1) BR9602630A (no)
CA (1) CA2223404C (no)
CZ (1) CZ285878B6 (no)
DE (1) DE69503066T2 (no)
DK (1) DK0789697T3 (no)
DZ (1) DZ2046A1 (no)
ES (1) ES2117426T3 (no)
FI (1) FI974441A0 (no)
HR (1) HRP960267B1 (no)
HU (1) HUP9601540A3 (no)
IL (1) IL118488A (no)
IS (1) IS4351A (no)
LV (1) LV11619B (no)
MA (1) MA23892A1 (no)
NO (1) NO305599B1 (no)
NZ (1) NZ286735A (no)
OA (1) OA10293A (no)
PE (1) PE38097A1 (no)
PL (1) PL314604A1 (no)
RU (1) RU2125571C1 (no)
SG (1) SG54339A1 (no)
SI (1) SI9600185A (no)
SK (1) SK280535B6 (no)
TN (1) TNSN96084A1 (no)
TW (2) TW580389B (no)
UA (1) UA44718C2 (no)
UY (1) UY25459A1 (no)
WO (1) WO1996039406A1 (no)
YU (1) YU34596A (no)
ZA (1) ZA964647B (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020032216A1 (en) 1997-03-21 2002-03-14 Lg Chemical Ltd. Salt of naphthyridine carboxylic acid derivative
MA24500A1 (fr) 1997-03-21 1998-10-01 Lg Life Sciences Ltd Derive du sel d'acide carboxylique de naphthyridine .
HN1998000106A (es) 1997-08-01 1999-01-08 Pfizer Prod Inc Composiciones parenterales de alatroflaxacino
DE19800214A1 (de) * 1998-01-06 1999-07-15 Knoll Ag Verfahren zur Herstellung von Doxazosin-Mcsylat in einer als Form A bezeichneten Kristallmodifikation und ein Zwischenprodukt dafür
US7019142B2 (en) * 1998-01-16 2006-03-28 Pfizer Inc. Process for preparing naphthyridones and intermediates
GB9818258D0 (en) * 1998-08-21 1998-10-14 Pfizer Ltd Antifungal compositions
HN1999000141A (es) * 1998-09-03 2000-06-19 Pfizer Prod Inc Procedimiento para preparar sales de trovafloxacina de adicion de acidos.
GB9820405D0 (en) 1998-09-18 1998-11-11 Smithkline Beecham Plc Process
ES2164520B1 (es) * 1999-03-16 2003-04-01 Medichem Sa "procedimiento de obtencion del polimorfo a del mesilato de doxazosina"
US6239141B1 (en) 1999-06-04 2001-05-29 Pfizer Inc. Trovafloxacin oral suspensions
GB9920917D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
GB9920919D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
US6660864B2 (en) 2001-06-29 2003-12-09 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6596871B2 (en) 2001-06-29 2003-07-22 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetraol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6573382B2 (en) 2001-06-29 2003-06-03 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6388080B1 (en) 2001-06-29 2002-05-14 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6657061B2 (en) 2001-06-29 2003-12-02 Grayson Walker Stowell Polymorphic forms of 6-[4-1(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6531603B1 (en) 2001-06-29 2003-03-11 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
KR100517638B1 (ko) 2002-04-08 2005-09-28 주식회사 엘지생명과학 게미플록사신 산염의 새로운 제조방법
CN102512364A (zh) * 2011-12-30 2012-06-27 天津市嵩锐医药科技有限公司 一种供注射用的甲磺酸阿拉曲伐沙星药物组合物
CN104884364B (zh) * 2013-01-11 2017-10-03 参天制药株式会社 内塞和具备该内塞的液体收容容器、以及喷嘴的前端构造和具备该构造的液体收容容器

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL166381B1 (pl) * 1989-08-16 1995-05-31 Pfizer Sposób wytwarzania nowych podstawionych kwasów 7-azabicyklochinolonokarboksylowych PL PL PL PL
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
CA2181351C (en) * 1994-01-18 1999-09-28 Tamim F. Braish Process and intermediates for preparing naphthyridonecarboxylic acid salts
GB2289674A (en) * 1994-05-23 1995-11-29 Pfizer Antibacterial naphthyridine

Also Published As

Publication number Publication date
DE69503066D1 (de) 1998-07-23
IS4351A (is) 1996-12-07
DK0789697T3 (da) 1998-10-19
AU5474996A (en) 1996-12-19
AU703634B2 (en) 1999-03-25
IL118488A0 (en) 1996-09-12
CA2223404C (en) 2001-01-16
JPH10506650A (ja) 1998-06-30
TW580389B (en) 2004-03-21
DZ2046A1 (fr) 2002-10-22
KR970001352A (ko) 1997-01-24
RU2125571C1 (ru) 1999-01-27
SI9600185A (en) 1997-04-30
SG54339A1 (en) 1998-11-16
NO305599B1 (no) 1999-06-28
ES2117426T3 (es) 1998-08-01
WO1996039406A1 (en) 1996-12-12
HRP960267B1 (en) 2000-06-30
SK280535B6 (sk) 2000-03-13
US5763454A (en) 1998-06-09
FI974441A7 (fi) 1997-12-05
LV11619A (lv) 1996-12-20
IL118488A (en) 1999-01-26
NZ286735A (en) 1998-01-26
AR002753A1 (es) 1998-04-29
DE69503066T2 (de) 1998-10-15
MA23892A1 (fr) 1996-12-31
LV11619B (en) 1997-04-20
FI974441L (fi) 1997-12-05
HUP9601540A3 (en) 1997-05-28
CN1148596A (zh) 1997-04-30
KR100191989B1 (ko) 1999-06-15
PE38097A1 (es) 1997-10-10
TNSN96084A1 (fr) 2005-03-15
UY25459A1 (es) 1999-11-17
BG100639A (bg) 1997-02-28
PL314604A1 (en) 1996-12-09
HU9601540D0 (en) 1996-07-29
BR9602630A (pt) 1998-09-08
ZA964647B (en) 1997-10-22
OA10293A (en) 1997-09-19
NO962321L (no) 1996-12-09
CZ285878B6 (cs) 1999-11-17
CN1055474C (zh) 2000-08-16
YU34596A (sh) 1999-03-04
HRP960267A2 (en) 1997-08-31
TW403751B (en) 2000-09-01
HUP9601540A2 (en) 1997-02-28
CA2223404A1 (en) 1996-12-12
SK71996A3 (en) 1997-03-05
CZ162596A3 (cs) 1998-09-16
FI974441A0 (fi) 1997-12-05
JP3145715B2 (ja) 2001-03-12
EP0789697A1 (en) 1997-08-20
BG62443B1 (bg) 1999-11-30
UA44718C2 (uk) 2002-03-15
EP0789697B1 (en) 1998-06-17
MX9709873A (es) 1998-03-31

Similar Documents

Publication Publication Date Title
NO962321L (no) Nye krystallformer av vannfritt 7-([1,5,6Å-6-amino-3-azabicyklo [3.1.0Å heks-3-yl)-6-fluoro-1-2,4-difluorfenyl)-1,4-dihydro-4-okso-1,8-naftyridin-3-karboksylsyre-metansulfonsyresalt
AP9600817A0 (en) Novel cryatal form of anhydrous 7-( [1A,5A,6A]-6-amino3-3-azabicyclo [3.1.0.] hex-3-yl) -6-fluro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1, 8-naphthyridine-3-carboxylic acid, methanesulfonic acid salt.
FI883807A7 (fi) Menetelmä farmakologisesti aktiivisten 7-(3-substituoitu-1-pyrrolidinyyli)-1-syklopropyyli-1,4-dihydro-4-okso-1,8-naftyridiini-3-karboksyylihappojohdannaisten valmistamiseksi
IS3873A (is) Hliðstæð aðferð til framleiðslu á kristölluðum oxaþíólan afleiðum
NO994595L (no) Salt av naftyridin-karboksylsyrederivat
DE3777735D1 (de) Imid-derivate, ihre herstellung und ihre verwendung.
FI873248A0 (fi) 7-((3-(aminometyl)-3-alkyl)-1 -pyrrolidinyl)-kinolin-karboxylsyror.
FI931332A0 (fi) Uusia alkyleenidiammoniumdiklavulanaattijohdannaisia, menetelmä niidenvalmistamiseksi samoin kuin niiden käyttö kalvulaanihapon puhdistamiseksi
NO923508D0 (no) Bicykliske karboksylsyrederivater
FI890723A0 (fi) Menetelmä kinoliinikarboksyylihappojohdannaisten valmistamiseksi
CA2344439A1 (en) Process for the production of a naphthyridine carboxylic acid derivative (methanesulfonate sesquihydrate)
IL142695A0 (en) Crystal modification b of 8-cyano-1-cyclopropyl-7-(1s,6s,-2, 8-diazabicyclo [4.3.0] nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid
ATE167478T1 (de) Kristallform von wasserfreien 7-((1a,5a,6a)-6- amino-3-azabicyclo (3.1.0.) hex-3-yl)-6-fluoro-1- (2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8- naphthyridin-carbonsäure methanesulfonsäure salz
NO20014059D0 (no) Krystallmodifikasjon D av 8-cyano-1-cyklopropyl-7-(1S,6S-2,8- diazabicyklo-/4.3.0/-nonan-8-yl)-6-fluor-1,4-dihydro-4-okso-3-kinolinkarboksylsyre
AP9600851A0 (en) Novel crystal form of anhydrous 7-(1A,5A,6A) -6- amino-3- azabicyclo(3.1.0)hex-3-YL) -6- fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo1,8-naphthyridine S-3-carboxylic acid methanesulfonic acid salt
ES2081674T3 (es) Derivados antibacterianos de los acidos 7-(aminometil-oxa-7-aza-biciclo-(3.3.0.)oct-7-il)quinolon- y naftiridon-carboxilico.
DE3779190D1 (de) T-butyl ergolinderivate.
CA2220080A1 (en) Method for making quinolone carboxylic acids or naphthyridine carboxylic acids in free base form
HUT57779A (en) Process for producing new thiazetoquinoline-3-carboxylic acid derivatives
FI934054A0 (fi) Menetelmä antibakteeristen karboksyylihappojohdannaisten valmistuksessa käyttökelpoisten välituotteiden valmistamiseksi
EA200100830A1 (ru) Производные 4-аминохиназолина и хинолина, оказывающие ингибирующее действие на преобразование сигнала, опосредованное тирозинкиназой
FI943730A0 (fi) Menetelmä angiotensiini-II-antagonistina aktiivisen 3-(2&#39;-N-bentsoyylisulfonamido-bifen-4-yyli)metyyli-5,7-dimetyyli-2-etyyli-3H-imidatso/4,5-b/pyridiinin valmistamiseksi
BG98448A (bg) 3-(заместени тетразолил)-4-оксо-4н-пиридо/1,2-а/пиримидини,техни соли,съдържащи ги фармацевтични продукти и метод за получаването им

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees